The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Lipoprotein (a). Heterogeneity and biological relevance.
Open accessAbstract
Lipoprotein (a), or Lp(a),' discovered by KAre Berg (1) more than 25 years ago, remains today a fascinating subject of re- search both because of its presumed association with athero- sclerotic cardiovascular disease (ASCVD) (2-14) and the many challenges it is offering to geneticists, structural biolo- gists, physiologists, epidemiologists, cardiologists, and clini- cians in general.Among these challenges is the elucidation of the remarkable heterogeneity exhibited by this lipoprotein particle, which is a key for understanding its biology.We will examine the various aspects of this heterogeneity and attempt to provide a global view on past and current knowledge on Lp(a) and identify those controversial areas where intensified research efforts are likely to provide important new advances. Physicochemical basis ofheterogeneityThe heterogeneity of Lp(a) went largely unrecognized until Harvie and Schultz (15) reported that their preparations of Lp(a) had a rather broad sedimentation coefficient distribu- tion, and that 25% of them exhibited a bimodal Schlieren peak.The first systematic study on Lp(a) heterogeneity was carried out in 1984 by Fless et al. (16), who not only confirmed the findings of Harvey and Schultz but by studying individual rather than pooled human blood samples also found that Lp(a) exhibits both inter-and intra-individual density heterogeneity, and that this heterogeneity is accounted for by differences in protein and lipid composition.In the same study, they also observed that apolipoprotein(a) [apo(a)], the specific marker of Lp(a), exhibits size heterogeneity owing to species that have electrophoretic mobility either less than, equal to, or greater than that of apo B100, the protein moiety of low density lipo- protein (LDL).In those studies it was also shown that apo(a) mass contributed to Lp(a) density in that the larger apo(a) was the main component of the denser particles and the smaller apo(a) was preferentially associated to Lp(a) particles of a low buoyant density.The importance of these studies did not be-
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
cDNA sequence of human apolipoprotein(a) is homologous to plasminogen
McLean, J. W., Tomlinson, J. E., Kuang, W.-J., Eaton, D. L., Chen, E. Y., Fless, G. M., Scanu, A. M., & Lawn, R. M. (1987) · Nature · doi:10.1038/330132a0 · Cited by 1,886 · cited 1×
“data (23) and the analysis of the apo(a) cDNA isolated from human liver libraries (24).”
BackgroundSelf-citation
Cited by
The Response-to-Retention Hypothesis of Early Atherogenesis
Williams, K. J., & Tabas, I. (1995) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.15.5.551 · Cited by 1,413
Nordestgaard, B. G., & Langsted, A. (2016) · Journal of Lipid Research · doi:10.1194/jlr.r071233 · Cited by 575
Schaefer, E. J. (1994) · JAMA · doi:10.1001/jama.1994.03510370051031 · Cited by 487
Williams, K. J., Fless, G. M., Petrie, K. A., Snyder, M. L., Brocia, R. W., & Swenson, T. L. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42208-9 · Cited by 205
Self-citationThe low density lipoprotein receptor is not required for normal catabolism of Lp(a) in humans.
Rader, D. J., Mann, W. A., Cain, W., Kraft, H. G., Usher, D., Zech, L. A., Hoeg, J. M., Davignon, J., Lupien, P., & Grossman, M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117794 · Cited by 176
Metadata
- Authors
- Scanu, A. M., & Fless, G. M.
- Venue
- Journal of Clinical Investigation
- Published
- 1990-06-01
- Volume
- 85
- Issue
- 6
- Pages
- 1709-1715
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2143308743
- Cited by
- 573
- References
- 1
- FWCI
- 72.77
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.